Skelaxin is a muscle relaxant. It works by blocking nerve impulses (or pain sensations) in the brain. Skelaxin is used together with rest and physical therapy to treat skeletal muscle conditions such as pain or injury. Skelaxin is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Metaxalone does not directly relax tense skeletal muscles in man.
Indications for use Skelaxin
Symptomatic treatment of painful and inflammatory processes of various origins, including:
inflammatory and degenerative diseases of the musculoskeletal system: rheumatoid arthritis; seronegative arthritis — ankylosing spondylitis (ankylosing spondylitis), psoriatic arthritis, reactive arthritis (Reiter’s syndrome); gout, pseudogout; osteoarthritis;
pain: weak, moderate and marked with tendinitis, bursitis, myalgia, neuralgia, sciatica; headache; migraine; post-traumatic and postoperative pain, including accompanied by inflammation and fever; pain syndrome in oncology; tuberculosis, inflammation of the pelvic organs, including adnexitis.
Before using the medication please consult with your doctor to avoid overdose Skelaxin and not cause a complication of the disease. The recommended dose for adults and children over 12 years of age is one 800 mg tablet three to four times a day. After buying Skelaxin carefully read the instructions on the drug or consult your physician.
Contraindications of Skelaxin
hypersensitivity to ketoprofen or other components of the drug, as well as salicylates or other NSAIDs;
complete or incomplete combination of bronchial asthma, recurrent nasal polyposis, and paranasal sinuses and intolerance of aspirin or other NSAIDs;
gastric ulcer or duodenal ulcer in the acute stage;
ulcerative colitis, Crohn’s disease;
hemophilia and other bleeding disorders;
children’s age (15 years);
severe hepatic impairment;
severe renal impairment, severe renal impairment (Cl creatinine less than 30 mL / min), confirmed hyperkalemia, progressive kidney disease;
uncompensated heart failure;
postoperative period after coronary artery bypass surgery;
gastrointestinal, and other cerebrovascular bleeding (bleeding or suspected);
III trimester of pregnancy;
Precautions: peptic ulcer history; the presence of Helicobacter pylori infection; bronchial asthma in history; symptomatic cardiovascular disease, cerebrovascular disease and peripheral arterial disease; dyslipidemia; liver failure; hyperbilirubinemia; alcoholic cirrhosis; chronic renal failure (Cl creatinine 30-60 ml / min); chronic heart failure; arterial hypertension; blood diseases; dehydration; diabetes; smoking; elderly age; long-term use of NSAIDs; concomitant treatment with anticoagulants (such as warfarin), antiplatelet agents (for example, acetylsalicylic acid, clopidogrel), oral corticosteroids (such as prednisone), SSRIs (such as citalopram, sertraline, paroxetine, fluoxetine).